Many pharmaceutical products are derived from human plasma and significantly enhance the quality of patients’ lives. As such, donated plasma is often a critical and life-saving part of patient treatment. But like other healthcare providers, plasma collectors face challenges. There is a rapidly growing demand for plasma used in pharmaceutical manufacturing. The regulatory requirements for plasma collection are stringent and costs are increasing. And while plasma collectors address these challenges, they are simultaneously trying to improve operational economics.

Through internal product development and acquisition, Haemonetics has significantly expanded its product offerings to comprise a full suite of blood management solutions – devices, information management systems, and services – that help our customers improve patient care while reducing costs.

Our definition of blood management is simple:

• Prevent a blood transfusion to the patient who doesn’t need one and
• Provide the right blood product at the right time for the patient who does need a transfusion.

Solutions That Meet Our Customers’ Needs

Our Plasma Division product portfolio supports increasing plasma supplies, automating manual business and blood collection processes, and improving efficiencies and compliance.